🇺🇸 FDA
Pipeline program

Proleukin 18 x 106 UI Polvere per soluzione iniettabile o per infusione, DC-VACCINE_IRSTIRCCS

IRST100.42

Phase 2 small_molecule active

Quick answer

Proleukin 18 x 106 UI Polvere per soluzione iniettabile o per infusione, DC-VACCINE_IRSTIRCCS for neuroendocrine tumors, soft tissue sarcoma is a Phase 2 program (small_molecule) at Istituto Gentili S.r.l. with 1 ClinicalTrials.gov record(s).

Program details

Company
Istituto Gentili S.r.l.
Indication
neuroendocrine tumors, soft tissue sarcoma
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials